Latest Insider Transactions at Avalo Therapeutics, Inc. (AVTX)
This section provides a real-time view of insider transactions for Avalo Therapeutics, Inc. (AVTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Avalo Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Avalo Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2022
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
83,000
+0.18%
|
$0
$0.77 P/Share
|
|
Feb 18
2022
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
55,000
+0.12%
|
$0
$0.82 P/Share
|
|
Feb 17
2022
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,000
+0.32%
|
$0
$0.82 P/Share
|
|
Jan 20
2022
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
12,000
+0.03%
|
$0
$0.85 P/Share
|
|
Jan 19
2022
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
93,700
+0.2%
|
$0
$0.88 P/Share
|
|
Jan 18
2022
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
206,300
+0.44%
|
$0
$0.88 P/Share
|
|
Jan 14
2022
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
85,000
+0.18%
|
$0
$0.93 P/Share
|
|
Jan 13
2022
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
312,700
+0.68%
|
$312,700
$1.0 P/Share
|
|
Jan 12
2022
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
57,300
+0.13%
|
$57,300
$1.04 P/Share
|
|
Jan 11
2022
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
16,003
+0.04%
|
$0
$0.96 P/Share
|
|
Jan 10
2022
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
491,097
+1.06%
|
$0
$0.99 P/Share
|
|
Jan 07
2022
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
137,900
+0.3%
|
$137,900
$1.04 P/Share
|
|
Dec 10
2021
|
Schond L. Greenway CFO |
BUY
Open market or private purchase
|
Direct |
2,231
+36.49%
|
$2,231
$1.57 P/Share
|
|
Dec 10
2021
|
Garry Arthur Neil CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
4,267
+4.75%
|
$4,267
$1.57 P/Share
|
|
Dec 10
2021
|
James Archie Harrell Jr Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
1,093
+2.89%
|
$1,093
$1.57 P/Share
|
|
Dec 10
2021
|
Christopher Ryan Sullivan Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
955
+9.59%
|
$955
$1.57 P/Share
|
|
Dec 10
2021
|
H Jeffrey Wilkins Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
6,371
+16.03%
|
$6,371
$1.57 P/Share
|
|
Sep 17
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,454,545
+10.81%
|
$10,909,090
$2.2 P/Share
|
|
Sep 16
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,000
+0.38%
|
$300,000
$2.28 P/Share
|
|
Sep 15
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
95,455
+0.24%
|
$190,910
$2.26 P/Share
|
|
Aug 18
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.05%
|
$40,000
$2.78 P/Share
|
|
Aug 16
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,000
+0.08%
|
$60,000
$2.75 P/Share
|
|
Aug 06
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,000
+0.06%
|
$50,000
$2.83 P/Share
|
|
Aug 05
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,000
+0.06%
|
$50,000
$2.77 P/Share
|
|
Aug 04
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.25%
|
$200,000
$2.69 P/Share
|
|
Jun 10
2021
|
H Jeffrey Wilkins Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
912
+3.27%
|
$1,824
$2.28 P/Share
|
|
Jun 10
2021
|
James Archie Harrell Jr Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
7,493
+17.36%
|
$14,986
$2.28 P/Share
|
|
Jun 10
2021
|
Schond L. Greenway CFO |
BUY
Open market or private purchase
|
Direct |
652
+28.3%
|
$1,304
$2.68 P/Share
|
|
Jun 10
2021
|
Garry Arthur Neil CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
3,692
+4.34%
|
$7,384
$2.28 P/Share
|
|
May 18
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
May 18
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
22,000
+0.06%
|
$44,000
$2.33 P/Share
|
|
May 17
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
May 17
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
30,000
+0.08%
|
$60,000
$2.2 P/Share
|
|
May 14
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
May 14
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
128,000
+0.33%
|
$256,000
$2.15 P/Share
|
|
Apr 15
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
0
|
-
|
|
Apr 15
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
6,285,715
+13.9%
|
$12,571,430
$2.0 P/Share
|
|
Jan 08
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jan 08
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,500,000
+7.12%
|
$5,000,000
$2.6 P/Share
|
|
Dec 10
2020
|
Garry Arthur Neil CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
3,599
+4.43%
|
$7,198
$2.28 P/Share
|
|
Dec 10
2020
|
Christopher Ryan Sullivan Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,095
+38.76%
|
$10,190
$2.28 P/Share
|
|
Dec 10
2020
|
James Archie Harrell Jr Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
171
+0.6%
|
$342
$2.28 P/Share
|
|
Dec 03
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Dec 03
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
20,000
+0.07%
|
$40,000
$2.44 P/Share
|
|
Nov 25
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Nov 25
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
15,000
+0.05%
|
$30,000
$2.39 P/Share
|
|
Nov 24
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Nov 24
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
47,733
+0.16%
|
$95,466
$2.4 P/Share
|
|
Nov 23
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Nov 23
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
37,267
+0.12%
|
$74,534
$2.32 P/Share
|